Industry Trends

Companies with technology platforms that address only a tiny part of the drug discovery process risk becoming optional or redundant accessories.

Intelligence systems are providing an answer to the avalanche of information in science and business.

Rapid progress in our understanding of immune function promises more effective treatments for autoimmune disorders.

With asthma cases on the rise, a better understanding of the disease on the molecular and systems levels promises more efficacious treatments.

The aging populations of developed countries are likely to present a growing market for arthritis therapies.

Prognostic/diagnostic testing and a raft of new drug targets from genomics promise to transform cardiovascular medicine.

Progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments.

Together with major international initiatives, companies are launching an offense against the world's most deadly parasitic disease.

Companies are racing to keep pace with the emergence of drug-resistant microorganisms.

The need for new treatments for AIDS is more urgent than ever.